Efficacy of orally administered Tramadol in reducing pain associated with hysteroscopic procedure
Phase 3
- Conditions
- Health Condition 1: null- ABNORMAL UTERINE BLEEDING
- Registration Number
- CTRI/2016/10/007394
- Lead Sponsor
- JIPMER GOVERNMENT HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
ALL WOMEN OF REPRODUCTIVE AGE GROUP UNDERGOING DIAGNOSTIC HYSTEROSCOPY
Exclusion Criteria
KNOWN ALLERGY TO TRAMADOL / OPIOIDS
CARDIAC OR RESPIRATORY DISEASE
KNOWN CASE OF LIVER OR KIDNEY DISEASE
KNOWN CASE OF EPILEPSY
NEUROLOGICAL/PSYCHIATRIC DISORDERS THAT AFFECT EVALUATION OF PAIN
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PAIN PERCEPTION USING VISUAL ANALOGUE SCALETimepoint: DURING HYSTEROSCOPY PROCEDURE <br/ ><br>IMMEDIATELY AFTER PROCEDURE <br/ ><br>30 MINUTES AFTER PROCEDURE
- Secondary Outcome Measures
Name Time Method 1)PROCEDURAL TIME- DEFINED AS TIME FROM INTRODUCTION OF HYSTEROSCOPE INTO EXTERNAL CERVICAL OS TO VISUALIZATION OF UTERINE CAVITY <br/ ><br>2)EASE OF ENTRYTimepoint: DURING HYSTEROSCOPY PROCEDURE <br/ ><br>IMMEDIATELY AFTER PROCEDURE <br/ ><br>30 MINUTES AFTER PROCEDURE